Mereo BioPharma Group Azioni (NASDAQ: MREO)

Mereo BioPharma Group (NASDAQ:MREO) Azioni

Mereo BioPharma Group

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Mereo BioPharma Group plc - American Depositary Shares

Mereo BioPharma Group PLC

Press Releases

Ultragenyx and Mereo BioPharma Announce New Phase 2 Data from Phase 2/3 Orbit Study Demonstrating Sustained Reductions in Fracture Rates Following Treatment with Setrusumab (UX143) in Patients with Osteogenesis Imperfecta (OI)

News

Financing

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Earnings

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Analyst Ratings

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

MREO

RARE

Absci

Abivax

Allogene Therapeutics, Inc. - Common Stock

Allogene Therapeutics

Altimmune

Benitec Biopharma

Celcuity

Cullinan Therapeutics, Inc. - Common Stock

Cullinan Therapeutics

COMPASS Pathways Plc - American Depository Shares

Compass Pathways

Erasca

Kura Oncology

Olema Pharmaceuticals, Inc. - Common Stock

Olema Pharmaceuticals

Oric Pharmaceuticals, Inc. - Common Stock

ORIC Pharmaceuticals

Oruka Therapeutics

Precigen

Prothena Corporation plc - Ordinary Shares

Prothena Corp

PureTech Health plc - American Depositary Shares

PureTech Health

Regulus Therapeutics

Regenxbio

Sage Therapeutics

Sana Biotechnology

Tectonic Therapeutic, Inc. - Common Stock

Tectonic Therapeutic

Tourmaline Bio

Upstream Bio

Verve Therapeutics

Verastem

Needham

JP Morgan

Cantor Fitzgerald

LifeSci Capital

Jefferies

Comments

Mereo BioPharma Group

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO